We are growing and creating companies that embody our core value of patient-centric, biomedical innovation.
Powered by Paragon
Castle Creek Pharma
Castle Creek Pharmaceuticals (CCP), part of the Paragon Biosciences portfolio of innovative biotech companies, is a privately held biopharmaceutical company developing innovative therapies for patients with rare, serious or debilitating dermatologic conditions. The company has a robust and diversified pipeline of late-stage products that have the potential to transform lives. For more information, please visit www.castlecreekpharma.com.
Harmony Biosciences is a biopharmaceutical company focused on identifying, developing, obtaining regulatory approval, and commercializing high-potential, innovative drugs to address unmet needs for patients with sleep and central nervous system (CNS) disorders.
Precision is a research and development driven organization focused on developing complex treatments in rare genetic oncology diseases.
Decade is a research and development company focused on novel Alzheimer’s disease therapeutics that will fundamentally improve patient outcomes and quality of life.